The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates. [electronic resource]
- Cancer chemotherapy and pharmacology Aug 2008
- 387-92 p. digital
Publication Type: Journal Article
0344-5704
10.1007/s00280-007-0616-3 doi
Animals Area Under Curve Erlotinib Hydrochloride Injections, Intravenous Macaca mulatta Male Metabolic Clearance Rate Quinazolines--administration & dosage